Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
18.88B
Market cap18.88B
Price-Earnings ratio
24.52
Price-Earnings ratio24.52
Dividend yield
0.95%
Dividend yield0.95%
Average volume
2.15M
Average volume2.15M
High today
$101.63
High today$101.63
Low today
$98.97
Low today$98.97
Open price
$100.20
Open price$100.20
Volume
1.31M
Volume1.31M
52 Week high
$108.29
52 Week high$108.29
52 Week low
$79.12
52 Week low$79.12

Stock Snapshot

The current Zimmer Biomet(ZBH) stock price is $98.97, with a market capitalization of 18.88B. The stock trades at a price-to-earnings (P/E) ratio of 24.52 and offers a dividend yield of 0.95%.

During the trading session on 2026-08-20, Zimmer Biomet(ZBH) shares reached a daily high of $101.63 and a low of $98.97. At a current price of $98.97, the stock is 0.0% higher than the low and still -2.6% under the high.

Trading volume for Zimmer Biomet(ZBH) stock has reached 1.31M, versus its average volume of 2.15M.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

The stock's 52-week range extends from a low of $79.12 to a high of $108.29.

ZBH News

MarketWatch 6h
Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

...

Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
The Motley Fool 12h
NeuroOne Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, Aug. 13, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Dave Rosa Chief Financial Officer - Chris Vo...

NeuroOne Q3 2026 Earnings Call Transcript
Simply Wall St 5d
Zimmer Biomet Holdings Could Be 2% Undervalued As Q2 Beat Lifts The Story

Zimmer Biomet Holdings (ZBH) is in focus after second quarter results topped Wall Street expectations, with management pointing to hip market share gains, expan...

Zimmer Biomet Holdings Could Be 2% Undervalued As Q2 Beat Lifts The Story

Analyst ratings

69%

of 29 ratings
Buy
31%
Hold
69%
Sell
0%

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.